Wednesday May 9 | The Sun Online
GLAXOSMITHKLINE fell 14p to 1410 as it took its A 1.6billion offer for biotech firm HUMAN GENOME SCIENCES direct to the US group's shareholders.
Wednesday May 9 | Independent.ie
Glaxo makes $2.6bn hostile bid for Human Genome
GLAXOSMITHKLINE has made a $2.6bn hostile takeover bid for Human Genome Sciences with a $13-a-share tender offer.